Title:
神経細胞性脳腫瘍など数種の腫瘍に対する新規免疫療法
Document Type and Number:
Japanese Patent JP5855940
Kind Code:
B2
Abstract:
The present invention relates to peptides, nucleic acids and cells for use in immunotherapeutic methods. In particular, the present invention relates to the immunotherapy of cancer. The present invention furthermore relates to tumor-associated cytotoxic T cell (CTL) peptide epitopes, alone or in combination with other tumor-associated peptides that serve as active pharmaceutical ingredients of vaccine compositions that stimulate anti-tumor immune responses. The present invention relates to 30 peptide sequences and their variants derived from HLA class I and class II molecules of human tumor cells that can be used in vaccine compositions for eliciting anti-tumor immune responses.
More Like This:
Inventors:
Shawl, oliver
Hirff, Norbert
Weinschenk, Toni
Troutvine, Claudia
Walther, Steffen
Jing, Hull Plate
Hirff, Norbert
Weinschenk, Toni
Troutvine, Claudia
Walther, Steffen
Jing, Hull Plate
Application Number:
JP2011529472A
Publication Date:
February 09, 2016
Filing Date:
September 28, 2009
Export Citation:
Assignee:
Imatics Biotechnology GM Behr
International Classes:
A61K39/00; A61K35/12; A61P35/00; C12N5/0783
Domestic Patent References:
| JP2009292810A |
Foreign References:
| US20050118588 | ||||
| WO2005116051A2 | ||||
| WO2007028573A2 |
Attorney, Agent or Firm:
Takashi Shoji
Previous Patent: セレノヒドロキシ酸化合物を使用してセレンが濃縮された光合成微生物、...
Next Patent: DEVELOPING METHOD BY ONE COMPONENT TYPE MAGNETIC DEVELOPER
Next Patent: DEVELOPING METHOD BY ONE COMPONENT TYPE MAGNETIC DEVELOPER